Florida Cancer Specialists & Research Institute, LLC (FCS) has submitted an application to participate in Medicare’s Enhancing Oncology Care Model (EOM), an alternative payment model that aims to address healthcare inequities, reduce costs and improve and report outcomes for cancer patients.
Physicians, clinicians and senior leaders of Florida Cancer Specialists & Research Institute, LLC (FCS) will continue their long history of active involvement with the Florida Society of Clinical Oncology (FLASCO) at the FLASCO Fall Session being held in Orlando, Oct. 28 & 29.
Florida Cancer Specialists & Research Institute (FCS) pleased to announce that Josh Eaves has been appointed as Chief Development & Strategy Officer, reporting to Chief Executive Officer Nathan H. Walcker.
Michael Diaz, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC (FCS), will co-chair the Payer Exchange Summit on Oncology Payment Reform presented by the Community Oncology Alliance (COA) on October 24 and 25, 2022 in Tysons Corner, VA.
Senior leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2022 Summit & Educational Program being held in New York, NY on Oct. 19-21.
Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes Board-certified medical oncologist/hematologist Judah Friedman, MD to the statewide practice.
Operations for Florida Cancer Specialists & Research Institute, LLC (FCS) were halted in all but one medical office last Thursday as Hurricane Ian made its way across Florida. The state-wide practice provides oncology care in nearly 100 locations in the state.
FCS Top News Updates
FCS Signals Next Chapter of Growth With Planned Leadership Transition and Focus on Innovation
Florida Cancer Specialists & Research Institute Applies For Participation in CMMI Enhancing Oncology ModelFlorida Cancer Specialists & Research Institute, LLC (FCS) has submitted an application to participate in Medicare’s Enhancing Oncology Care Model (EOM), an alternative payment model that aims to address healthcare inequities, reduce costs and improve and report outcomes for cancer patients.
Florida Cancer Specialists & Research Institute Announces Executive Leadership AppointmentFlorida Cancer Specialists & Research Institute (FCS) pleased to announce that Josh Eaves has been appointed as Chief Development & Strategy Officer, reporting to Chief Executive Officer Nathan H. Walcker.
Florida Cancer Specialists & Research Institute President Michael Diaz, MD Joins U.S. Cancer Care Stakeholders To Review Oncology Payment Reform InitiativesMichael Diaz, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC (FCS), will co-chair the Payer Exchange Summit on Oncology Payment Reform presented by the Community Oncology Alliance (COA) on October 24 and 25, 2022 in Tysons Corner, VA.
FCS Leaders Serve on 2022 Faculty for Value-Based Cancer Care SummitSenior leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2022 Summit & Educational Program being held in New York, NY on Oct. 19-21.
Judah Friedman, MD Joins Florida Cancer Specialists & Research Institute Providing Care in Palm BeachFlorida Cancer Specialists & Research Institute, LLC (FCS) welcomes Board-certified medical oncologist/hematologist Judah Friedman, MD to the statewide practice.
Targeted Radioligand Therapy for Metastatic Prostate CancerPluvicto ™, the first targeted radioligand therapy approved to treat an advanced prostate cancer.
Florida Cancer Specialists & Research Institute Quick to Rebound Following Hurricane IanOperations for Florida Cancer Specialists & Research Institute, LLC (FCS) were halted in all but one medical office last Thursday as Hurricane Ian made its way across Florida. The state-wide practice provides oncology care in nearly 100 locations in the state.